HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Heverhagen, J. T. Articles by Hellinger, A. Search for Related Content PubMed PubMed Citation Articles by Heverhagen, J. T. Articles by Hellinger, A.

Pancreatic Transplants: Noninvasive Evaluation with Secretin-augmented MR Pancreatography and MR Perfusion Measurements—Preliminary Results¹

¹ From the Departments of Diagnostic Radiology (J.T.H., H.J.W., K.J.K.), Surgery (H.E.), and Nephrology (A.H.), University Hospital, Philipps University, Marburg, Germany; and Department of Radiology, Ohio State University, 645 Means Hall, 1654 Upham Dr, Columbus, OH 43210 (J.T.H., A.L.L.). Received July 26, 2003; revision requested October 9; revision received January 11, 2004; accepted February 4. Address correspondence to J.T.H. (e-mail: heverhagen@gmx.net).

Feasibility of secretin-augmented magnetic resonance (MR) pancreatography and dynamic contrast material–enhanced MR measurements for evaluation of functional status of pancreatic allografts was determined by quantifying the excretion and perfusion of the grafts. Ten patients were included prospectively before pancreatic transplantation. Dynamic T2-weighted sequences after secretin stimulation and dynamic contrast-enhanced T1-weighted gradient-echo sequences were performed. Area under the curve and maximum signal intensity–to-time ratio were determined in selected regions of interest. Biochemical parameters, Doppler ultrasonography, and/or surgery were standards for final diagnosis. Patients with normal outcome (n = 7) produced 236 mL ± 104 (standard deviation) of pancreatic juice, and patients with dysfunctional grafts (n = 3) produced 42 mL ± 25. Area under the curve and maximum signal intensity–to-time ratio provided thresholds of 0.5 and 0.3, respectively, for distinction between functional and dysfunctional grafts. Secretin-augmented MR pancreatography combined with MR perfusion measurements may aid in differentiation between patients with and those without graft dysfunction.

© RSNA, 2004

Index terms: Magnetic resonance (MR), perfusion study, 770.12144 • Pancreas, function • Pancreas, MR, 770.121411, 770.121412, 770.12143, 770.12144 • Pancreas, transplantation

This article has been cited by other articles:

				J. T. Heverhagen Noise Measurement and Estimation in MR Imaging Experiments Radiology, December 1, 2007; 245(3): 638 - 639. [Full Text] [PDF]